Application of Intrahepatic Arterial Infusion Chemotherapy for Patients With High Risk of Liver Metastases After Pancreatic Cancer Surgery

Clinical trial NCT03687853 · UNKNOWN

Trial details

NCT number: NCT03687853
Sponsor: Peking University Third Hospital
Status: UNKNOWN
Phase: Not Applicable
Study type: INTERVENTIONAL

Pancreatic Ductal Adenocarcinoma Who Have High CTCs Count in Portal Venous Blood Liver Metastases

Start date: 2017-01-01
Primary completion: 2018-12-31
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.